Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Genetics and pulmonary medicine. 4. Pulmonary embolism.

Literature DB >> 9828859

Genetics and pulmonary medicine. 4. Pulmonary embolism.

M Laffan¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1998 PMID： 9828859 PMCID： PMC1745294 DOI： 10.1136/thx.53.8.698

Source DB: PubMed Journal: Thorax ISSN： 0040-6376 Impact factor: 9.139

Keyword Cloud
References

× No keyword cloud information.

48 in total

1. Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor.

Authors: P M Ridker; D E Vaughan; M J Stampfer; J E Manson; C Shen; L M Newcomer; S Z Goldhaber; C H Hennekens
Journal: Circulation Date: 1992-05 Impact factor: 29.690

2. Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan.

Authors: R D Hull; J Hirsh; C J Carter; R M Jay; P E Dodd; P A Ockelford; G Coates; G J Gill; A G Turpie; D J Doyle; H R Buller; G E Raskob
Journal: Ann Intern Med Date: 1983-06 Impact factor: 25.391

3. Thrombomodulin gene mutations associated with myocardial infarction.

Authors: H Ireland; G Kunz; K Kyriakoulis; P J Stubbs; D A Lane
Journal: Circulation Date: 1997-07-01 Impact factor: 29.690

4. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis.

Authors: I Juhan-Vague; J Valadier; M C Alessi; M F Aillaud; J Ansaldi; C Philip-Joet; P Holvoet; A Serradimigni; D Collen
Journal: Thromb Haemost Date: 1987-02-03 Impact factor: 5.249

5. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis.

Authors: H Heijboer; D P Brandjes; H R Büller; A Sturk; J W ten Cate
Journal: N Engl J Med Date: 1990-11-29 Impact factor: 91.245

6. Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep vein thrombosis. A randomized trial.

Authors: D J Doyle; A G Turpie; J Hirsh; C Best; D Kinch; M N Levine; M Gent
Journal: Ann Intern Med Date: 1987-10 Impact factor: 25.391

Genetics and pulmonary medicine. 4. Pulmonary embolism.

1. Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor.

2. Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan.

3. Thrombomodulin gene mutations associated with myocardial infarction.

4. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis.

5. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis.

6. Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep vein thrombosis. A randomized trial.

7. Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis.

8. The significance of venography in the management of patients with clinically suspected pulmonary embolism.

9. Thrombovascular disease and familial plasminogen deficiency: a report of three kindreds.

10. The clinical spectrum of heterozygous protein C deficiency in a large New England kindred.